Skip to main content

Newsroom press releases

29/12/20 - 18:22

DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance (400.67 KB)
Products Molecular
Download

17/12/20 - 17:57

DiaSorin - Policlinico San Matteo Hospital in Pavia vs. Technogenetics (298.96 KB)
Other
Download

07/12/20 - 10:35

Communication on total amount of voting rights (563.18 KB)
Other
Download

04/12/20 - 16:14

Form 3F (November 2020) (10.2 KB)
Other
Download

01/12/20 - 6:33

DiaSorin received FDA approval for its LIAISON® XL MUREX HIV Ab/Ag assay, completing the Hepatitis and Retrovirus offer in the US market (566.6 KB)
Products Immunodiagnostic
Download

11/11/20 - 12:41

North America growth drives up revenues and profitability in the first 9 months of 2020 (805.25 KB)
Financial Data
Download

26/10/20 - 18:30

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients (414.59 KB)
Products Immunodiagnostic
Download

23/10/20 - 19:41

Conclusion treasury shares buy-back plan (314.28 KB)
Other
Download

23/10/20 - 19:37

Weekly report treasury shares buy-back (436.92 KB)
Other
Download

16/10/20 - 18:28

Weekly report treasury shares buy-back (425.19 KB)
Other
Download

01/10/20 - 7:45

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market (395.31 KB)
Products Immunodiagnostic
Download

01/10/20 - 7:32

DiaSorin’s LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authorization for the U.S. market (488.09 KB)
Products Immunodiagnostic
Download

23/09/20 - 7:16

DiaSorin extends its current joint venture with the Chinese Government to open a new manufacturing and research site in China (495.78 KB)
Acquisition / Partnership
Download

16/09/20 - 14:30

Update Annual Calendar of Corporate Events 2020 (222.26 KB)
Other
Download

16/09/20 - 7:25

DiaSorin Simplexa™ COVID-19 Direct molecular test CE marked for saliva specimens (477.67 KB)
Products Molecular
Download

08/09/20 - 7:31

DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution (506.16 KB)
Acquisition / Partnership
Download

07/09/20 - 18:22

FDA approval of Simplexa flu A_B & RSV Direct Gen II Assay (400.26 KB)
Products Molecular
Download

06/08/20 - 7:25

DiaSorin announces the launch of its new CE marked LIAISON Testosterone xt test for the dosage of testosterone (391.91 KB)
Products Immunodiagnostic
Download

31/07/20 - 16:04

Weekly report treasury shares buy-back (380.16 KB)
Other
Download

30/07/20 - 13:16

North America business growth drives Group revenues and profitability in H1 2020 (735.54 KB)
Financial Data
Download

24/07/20 - 17:19

Weekly report treasury shares buy-back (363.73 KB)
Other
Download

17/07/20 - 18:19

Weekly report treasury shares buy-back (360.09 KB)
Other
Download

10/07/20 - 18:23

Weekly report treasury shares buy-back (374 KB)
Other
Download

09/07/20 - 7:27

DiaSorin will provide the UK Government with its LIAISON SARS-CoV-2 S1/S2 IgG serology kit for COVID-19 testing to run a national screening study (399.63 KB)
Products Immunodiagnostic
Download

07/07/20 - 7:22

DiaSorin CE marks their new Simplexa Flu A/B & RSV Direct Gen II Assay to run with the Simplexa COVID-19 Direct assay (490.1 KB)
Products Molecular
Download

30/06/20 - 7:25

DiaSorin announces the launch of its new LIAISON® SARS-COV-2 IgM test, a new fully automated serology kit available in Europe and in the U.S. to identify the immediate response to SARS-COV-2 in COVID-19 patients (397.37 KB)
Products Immunodiagnostic
Download

19/06/20 - 17:20

Weekly report treasury shares buy-back (399.38 KB)
Other
Download

17/06/20 - 16:09

Start up of the treasury shares buy-back plan (481.28 KB)
Other
Download

12/06/20 - 7:30

DiaSorin has CE marked its molecular's Simplexa™ Congenital CMV Direct Assay (478.6 KB)
Products Molecular
Download

10/06/20 - 15:40

Shareholders' Meeting June 10, 2020 (308.25 KB)
Other
Download

03/06/20 - 14:16

The LIAISON® SARS-COV-2 S1/S2 IgG test received the approval for the commercialization in Brazil from ANVISA (397.21 KB)
Products Immunodiagnostic
Download

02/06/20 - 14:58

Communication total amount voting rights (record date) (267.83 KB)
Download

18/05/20 - 11:28

The LIAISON® SARS-COV-2 S1S2 IgG test is the first to receive the approval from Health Canada (308.26 KB)
Products Immunodiagnostic
Download

13/05/20 - 13:15

DiaSorin Group reports revenue growth and confirmed profitability in the first quarter 2020 despite the impact of the pandemic (741.65 KB)
Financial Data
Download

25/04/20 - 16:49

DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG (403.66 KB)
Products Immunodiagnostic
Download

17/04/20 - 18:25

DiaSorin has CE marked its SARS-COV-2 IgG serology kit for COVID-19 (464.49 KB)
Products Immunodiagnostic
Download

07/04/20 - 7:14

IgG test to detect immune response to SARS-CoV-2 (394.92 KB)
Products Immunodiagnostic
Download

26/03/20 - 18:14

Update Annual Calendar of Corporate Events 2020 (277.25 KB)
Other
Download

21/03/20 - 20:29

Shareholders' Meeting date change (288.23 KB)
Other
Download

20/03/20 - 7:28

DiaSorin COVID-19 test has received FDA Emergency Use Authorization (397.04 KB)
Products Molecular
Download

13/03/20 - 17:16

DiaSorin received BARDA funding to develop a rapid COVID-19 test (403.34 KB)
Products Molecular
Download

11/03/20 - 13:43

DiaSorin - Cash flow generation and net profit hit record highs in 2019 (919.6 KB)
Financial Data
Download

10/03/20 - 8:20

DiaSorin - Development of Coronavirus test (404.03 KB)
Products Molecular
Download

02/03/20 - 8:04

DiaSorin signs an exclusive licensing agreement for molecular diagnostic POC technology (396.06 KB)
Acquisition / Partnership
Download

07/02/20 - 8:06

Communication on total amount of voting rights (281.13 KB)
Other
Download

15/01/20 - 16:51

Annual Calendar of Corporate Events 2020 (124.73 KB)
Other
Download

21/12/18 - 11:30

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)
Products Molecular
Download

04/12/18 - 8:00

DiaSorin's stocks listed in the FTSE MIB (464.63 KB)
Financial Data
Download

19/11/18 - 15:00

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)
Products Molecular
Download

07/11/18 - 13:00

DiaSorin Group reports growth in revenues and net profit in the first nine months of 2018 (961.72 KB)
Financial Data
Download

17/10/18 - 11:51

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)
Products Molecular
Download

12/10/18 - 11:47

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)
Products Molecular
Download

09/10/18 - 11:35

DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom (471.21 KB)
Acquisition / Partnership
Download

17/09/18 - 11:28

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)
Products Immunodiagnostic
Download

07/08/18 - 8:45

Communication on total amount of voting rights (305.24 KB)
Financial Data
Download

02/08/18 - 12:45

The Board of Directors approves the results for the first half of 2018 (883.1 KB)
Financial Data
Download

27/07/18 - 12:00

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)
Products Immunodiagnostic
Download

03/07/18 - 18:30

Conclusion treasury shares buy-back plan (397.33 KB)
Financial Data
Download

03/07/18 - 18:30

Annex 3F (treasury shares buy back July 2018) (6.59 KB)
Financial Data
Download

03/07/18 - 18:30

Report treasury shares buy-back (287.99 KB)
Financial Data
Download

03/07/18 - 18:30

Annex 3F (treasury shares buy back June 2018) (8.69 KB)
Financial Data
Download

29/06/18 - 18:15

Weekly report treasury shares buy-back (290.62 KB)
Financial Data
Download

22/06/18 - 20:30

Weekly report treasury shares buy-back (290.6 KB)
Financial Data
Download

15/06/18 - 21:00

Weekly report treasury shares buy-back (290.62 KB)
Financial Data
Download

12/06/18 - 14:15

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)
Products Molecular
Download

08/06/18 - 23:15

Weekly report treasury shares buy-back (290.24 KB)
Financial Data
Download

04/06/18 - 13:15

Annex 3F (treasury shares buy back May 2018) (8.54 KB)
Financial Data
Download

01/06/18 - 20:15

Weekly report treasury shares buy-back (290.38 KB)
Financial Data
Download

25/05/18 - 22:30

Weekly report treasury shares buy-back (289.97 KB)
Financial Data
Download

19/05/18 - 1:45

Weekly report treasury shares buy-back (289.76 KB)
Financial Data
Download

11/05/18 - 20:15

Weekly report treasury shares buy-back (290.77 KB)
Financial Data
Download

08/05/18 - 14:30

The DiaSorin Group reports growth in revenues and profitability in the first quarter 2018 (832.84 KB)
Financial Data
Download

03/05/18 - 20:15

Start up treasury shares buy-back plan (354.27 KB)
Financial Data
Download

24/04/18 - 14:00

Annex 3F (treasury shares buy back) (7.77 KB)
Financial Data
Download

23/04/18 - 18:30

Annual General Meeting 2018 (589.65 KB)
Financial Data
Download

19/04/18 - 21:15

Conclusion treasury shares buy-back plan (397.59 KB)
Financial Data
Download

19/04/18 - 21:00

Weekly report treasury shares buy-back (289.29 KB)
Financial Data
Download

13/04/18 - 20:30

Weekly report treasury shares buy-back (290.07 KB)
Financial Data
Download

06/04/18 - 19:45

Weekly report treasury shares buy-back (288.33 KB)
Financial Data
Download

05/04/18 - 12:00

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)
Products Immunodiagnostic
Download

04/04/18 - 20:00

Start up treasury shares buy-back plan (346.04 KB)
Financial Data
Download

28/03/18 - 18:45

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)
Products Molecular
Download

07/03/18 - 15:30

DiaSorin: FY 2017 Results (1.14 MB)
Financial Data
Download

30/01/18 - 11:45

DiaSorin signs an agreement with the Italian Tax Authority granting tax relief under the Italian Patent Box regime (574.68 KB)
Financial Data
Download

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership
Download

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership
Download
Price Sensitive

eMarket SDIR System and eMarket STORAGE
For the dissemination and the storage of Regulated Information, DiaSorin S.p.A. uses the eMarket SDIR circuit and the eMarket STORAGE mechanism (available at the address www.emarketstorage.it), managed by Teleborsa S.r.l., with registered office in Piazza di Priscilla, 4, Rome, Italy.